Article
Adverse impact of a high allelic burden FLT3-ITD mutation on allogeneic hematopoietic stem cell transplantation in patients with cytogenetically normal AML.
International journal of hematology - 1 Nov 2022
Wan Li, Ding Shuqi, Xu Mimi, Lv Kangkang, Du Yuanyuan, Wu Depei, Xu Mingzhu, Liu Yuejun
Abstract excerpt
Risks associated with the FLT3-ITD mutation in patients receiving chemotherapy alone for cytogenetic normal acute myeloid leukemia (CN-AML) depend on the allelic ratio (AR) and concomitant NPM1 mutation. Nevertheless, their prognostic ability after allogeneic hematopoietic cell transplantation (allo-HCT) remains undetermined. Moreover, previous studies have revealed that haploidentical transplantation improves...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
